People using two different inhalers for common chronic lung diseases are more than 50 percent more likely to have a heart attack than those on just one, new University of Otago-led research reveals. Inhaled...

A world-leading research collaboration in South Australia has delivered crucial insight into the lasting immune system dysregulation caused by COVID-19. The study, conducted by experts at SAHMRI, Flinders...

An early phase trial of a drug currently used to treat lung fibrosis has shown it may also help patients who suffer from a common form of heart failure. Trialed by University of Manchester and Manchester...

Easy Ways to Live Well: Steph McGovern discusses bloating We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from...

Ebola: Guinea Health Agency head declares 'pandemic' in February We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include...

PARIS (Reuters) – Vandals have attacked more than 20 vaccination centres and other health facilities, daubing some with Nazi-themed slogans, as the French government steps up its COVID-19 vaccination...

NEW YORK (Reuters Health) – Intravitreal injections of aflibercept can reduce the severity of nonproliferative diabetic retinopathy (NPDR), according to the results of an international sham-controlled...

Bioengineers at the University of California San Diego have developed a cancer immunotherapy that pairs ultrasound with cancer-killing immune cells to destroy malignant tumors while sparing normal tissue. The...

Over 70% of young people aged 18 to 29 in England have received a first dose of a COVID-19 vaccine, the latest figures show, providing vital protection against infection and serious illness from the...

A new strategy for modeling the spread of COVID-19 incorporates smartphone-captured data on people’s movements and shows promise for aiding development of optimal lockdown policies. Ritabrata Dutta...